Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion—A subanalysis of the EXPLORE trial

• Published in: Catheterization and cardiovascular interventions 2021-05, Vol.97 (6), p.1176-1183
• Main Authors: Kolk, Maarten Z. H., Veelen, Anna, Agostoni, Pierfrancesco, Houwelingen, Gert K., Ouweneel, Dagmar M., Hoebers, Loes P., Råmunddal, Truls, Laanmets, Peep, Eriksen, Erlend, Bax, Matthijs, Suttorp, Maarten J., Claessen, Bimmer E. P. M., Schaaf, René J., Elias, Joëlle, Dongen, Ivo M., Henriques, José P. S.
• Format: Article
• Language: English
• Subjects: Angioplasty; CMR; CTO; ECG; EKG; Electrocardiography; Heart; Magnetic resonance imaging; Myocardial infarction; Myocardium; Occlusion; PCI; STEMI; Ventricle
• ISSN: 1522-1946; 1522-726X
• DOI: 10.1002/ccd.28904

Objective To evaluate predictors of procedural success of percutaneous coronary intervention (PCI) of chronic total coronary occlusions (CTOs) in a non‐infarct‐related artery following ST‐segment elevation myocardial infarction (STEMI), and demonstrate the effect on left ventricular functionality (LVF), infarct size (IS), and pro‐arrhythmic electrocardiogram (ECG) parameters. Background Predictors of unsuccessful revascularization of a CTO are numerous, although following STEMI, these are lacking. Besides, effects of failed CTO PCI (FPCI) on the myocardium are unknown. Methods This is a subanalysis of the EXPLORE trial, in which 302 STEMI patients with a concurrent CTO were randomized to CTO PCI (n = 147) or no‐CTO PCI (NPCI, n = 154). For the purpose of this subanalysis, we divided patients into successful CTO PCI (SPCI, n = 106), FPCI (n = 41), and NPCI (n = 154) groups. Cardiac magnetic resonance imaging and angiographic data were derived from the EXPLORE database, combined with ECG parameters. To gain more insight, all outcomes were compared with patients that did not undergo CTO PCI. Results In multivariate regression, only CTO lesion length >20 mm was an independent predictor of procedural failure (OR 3.31 [1.49–7.39]). No significant differences in median left ventricular ejection fraction, left ventricular end‐diastolic volume, IS, and the pro‐arrhythmic ECG parameters such as QT‐dispersion, QTc‐time, and TpTe‐intervals were seen between the SPCI and FPCI groups at 4 months follow‐up. Conclusion This subanalysis of the EXPLORE trial has demonstrated that a CTO lesion length >20 mm is an independent predictor of CTO PCI failure, whereas procedural failure did not lead to any adverse effects on LVF nor pro‐arrhythmic ECG parameters.